Patient Compliance With Long-Acting Reversible Contraception Administration

T

Tulane University School of Medicine

Status

Terminated

Conditions

Contraception

Treatments

Device: Levonorgestrel IUD, copper IUD, etonorgestrel implant

Study type

Interventional

Funder types

Other

Identifiers

NCT03305081
IRBNet ID 628424-1

Details and patient eligibility

About

This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum hospital stay, either in the immediate or early postpartum period, versus b) during the interval postpartum period as previously done.

Full description

Randomized control trial with control group receiving LARC at 6 weeks postpartum and the study group receiving LARC in the immediate or early postpartum period. Outcomes will be measured by those who receive or do not receive LARC either in the hospital after delivery versus 6 weeks postpartum in accordance with the study subjects' randomized designation. Secondary outcomes of bleeding profile and satisfaction will also be assessed.

Enrollment

45 patients

Sex

Female

Ages

15+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Pregnant, desires LARC postpartum

Exclusion criteria

Medical contraindication to desired LARC, vaginal delivery complicated by fourth degree perineal laceration, history of pelvic inflammatory disease, uterine infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 2 patient groups

Immediate or early placement
Experimental group
Description:
Immediate or early placement of levonorgestrel IUD, copper IUD, or etonorgestrel sub dermal implant (within 48 hours) postpartum
Treatment:
Device: Levonorgestrel IUD, copper IUD, etonorgestrel implant
Interval placement
Active Comparator group
Description:
Interval (4-6 weeks) postpartum placement of levonorgestrel IUD, copper IUD, or etonorgestrel sub dermal implant
Treatment:
Device: Levonorgestrel IUD, copper IUD, etonorgestrel implant

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems